Sevelamer Carbonate Tablet, Film Coated
Product Images NDC 71205-966

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 71205-966). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)

Sevelamer Carbonate Chemical Structure (7397sevelamerimage 01)
Chemical structure diagram showing the molecular components of Sevelamer Carbonate. The image includes labeled primary amine groups, crosslinking groups, and an extended polymer network characteristic of the active ingredient's polymeric structure.*
FDA Label Image

Figure 2 (7397sevelamerimage 02)

Figure 2 (7397sevelamerimage 02)
A line graph showing the percentage of patients with at least a 2-fold reduction in serum phosphorus versus the reduction in serum phosphorus (mg/dL). It compares Sevelamer Hydrochloride and an active control, illustrating changes from baseline with directions for worsening increase and improvement reduction.*
FDA Label Image

Graph (7397sevelamerimage 03)

Graph (7397sevelamerimage 03)
A line graph showing phosphorus change from baseline over 52 study weeks comparing Sevelamer Hydrochloride and an Active Control treatment. The x-axis represents study weeks (0 to 52) and the y-axis represents phosphorus change from baseline, ranging from -5 to 2. Two lines plot phosphorus levels for each treatment group across time points.*
FDA Label Image

Twi (B5862d67 Figure 04)

FDA Label Image

71205-966-67 (Label 800 mg)

71205-966-67 (Label 800 mg)
Label for Sevelamer Carbonate 800 mg film-coated tablets by Proficient Rx LP. The label includes the product name, strength, dosage form, and quantity (#270 tablets). It states the manufacturer as TWI Pharmaceuticals, Inc., with storage instructions and a caution to keep medication out of reach of children. The label also includes NDC 71205-966-67 and imprint details for the tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.